To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Possible antitumor substances in red wine are formed during ageing in oak barrels
Polyphenols not only give red wine its characteristic dry flavor, they are also
the basis for the recent good reputation of this stimulant as a true health
drink. They are believed to prevent heart disease and atherosclerosis. French
researchers working with Stéphane Quideau have now discovered more examples of
polyphenols in red wine, and these could have anticancer activity.
Polyphenols are a large class of substances that act as tannins and pigments in many fruits and vegetables. "A number of these substances have already made their way into medicine, but the potential has not been exhausted by a long shot," says Quideau. He and his team have now found another interesting compound in red wine. Acutissimin A is a flavano ellagitannin, meaning that it has both flavonoid and tannin components. The substance was first discovered in the oak species Quercus acutissima, from which it takes its name. What makes acutissimin A so attractive is its inhibitory effect on DNA topoisomerase II, because this enzyme is a target in cancer treatment. Acutissimin A inhibits this enzyme 250 times more strongly than the clinically used antitumor agent Etoposid.
The French team was able to produce acutissimin A semisynthetically in the laboratory by binding together the flavanoid catechin and the tannin vescalagin. If an isomer of catechin, epicatechin, is used, a closely related but previously unknown compound, which the researchers called "epiacutissimin", is formed. The team was later also able to detect this substance in red wine extracts.
How do acutissimin and epiacutissimin get into red wine? It's the ageing in oak barrels! Says Quideau: "The grape juice contains the flavonoid precursors catechin and epicatechin. During storage, the alcoholic liquid then extracts a whole bouquet of substances out of the oak barrels, including the necessary co-reactant, vescalagin." Quideau and his colleagues won't go so far as to call wine a cancer preventative. But one can hardly wait to see what surprises red wine has in store for us next. The probability is high that these precious drops contain more tannin hybrid molecules with interesting pharmacological activity.
- 1Caflon® surfactants from Univar as substitutes for banned nonylphenol ethoxylates
- 2Knoll AG: Pharma business sold for $6.9 billion:
- 3New Fluka and Riedel-de Haën Catalog Features Over 1,500 New Products
- 4BASF: Fertilizer from Plastic Waste
- 5Allegra® Launched in Japan
- 6Dow Announces Shutdown of Union Carbide Manufacturing Facility in Bound Brook, New Jersey
- 7Fluopicolide from Bayer CropScience receives registrations in Japan and the United States
- 8Drew Industrial Division of Ashland Specialty Chemical Company purchases industrial water-treatment business of London-based Fernox
- 9Stockhausen, a subsidiary of Degussa, develops a special product for de-inking and de-watering of sludge
- 10Plurafac LF 303 - Plurafac LF 305: The new generation of low-foam surfactants
- Energy researchers discover new structure for bimetallic catalysts
- Newly discovered 'design rule' brings nature-inspired nanostructures one ste ...
- Dirt-cheap catalyst may lower fuel costs for hydrogen-powered cars
- Researchers aim to develop new techniques for creating high-temperature alloys
- Molecular nanoribbons as electronic highways